熱門資訊> 正文
InterCure将与Cookie的战略合作伙伴关系扩大到德国
2024-08-28 21:09
- InterCure (NASDAQ:INCR) said it has entered into a new strategic agreement with Cookies.
- The agreement is to cultivate, manufacture, import and distribute Cookies’ branded products, produced from its cultivation and manufacturing facilities, initially in eight licensed branded pharmacies across Germany, through Cookies Corners.
- Under the agreement, the company will cultivate, and manufacture Cookies licensed genetics and products at its global supply chain facilities.
More on InterCure
- InterCure: A Cannabis Industry Leader Still Flying Under The Radar
- Financial information for InterCure
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。